Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 2/2014

01-08-2014 | Case Report

HPV-related cervical disease and oropharyngeal cancer

Authors: Virginia Lozza, Annalisa Pieralli, Serena Corioni, Manuela Longinotti, Claudia Bianchi, Daniela Moncini, Maria Grazia Fallani

Published in: Archives of Gynecology and Obstetrics | Issue 2/2014

Login to get access

Abstract

Human papillomavirus (HPV), especially HPV 16, is associated with the development of both cervical and oral cancer. We show the case of a woman affected by HPV-related cervical disease and oropharyngeal squamous cell carcinoma (OPSCC). A 41-year-old woman arrived at our Colposcopy Center following an abnormal Pap smear result (ASC-H) and a diagnosis of moderate cervical dysplasia obtained by a cervical biopsy. She underwent a colposcopy that showed a cervical abnormal transformation zone grade 2. A laser conization was performed in November 2010. Histology reported a moderate/severe dysplasia. The cone resection margins were free. Follow-up colposcopy and cytology were negative. The HPV testing showed an infection by HPV 16. In October 2012, the patient presented to the Head–Neck ER after episodes of hemoptysis; a lesion was found in the left tonsillar lodge. A biopsy was performed with a result of squamous cell carcinoma with low-grade differentiation. The HPV testing detected a high-risk HPV and the immunohistochemical analysis was positive for p16. She was treated by chemotherapy and brachytherapy. She was followed at the head–neck center with monthly visits with oral visual inspection that showed complete absence of mucosal abnormalities. HPV-related OPSCC and cervical precancerous/cancerous lesions have significant similarities in terms of pathogenesis. They are both caused largely by HPV 16, as in the present case. In conclusion, because of this association found in literature and in our case, we think that women with HPV cervical lesions should have regular surveillance for oropharyngeal cancer, whereas women with OPSCC should be encouraged to have diligent cervical screening.
Literature
1.
go back to reference Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer incidence in five continents, vol I–VIII. IARC CancerBase, Lyon Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer incidence in five continents, vol I–VIII. IARC CancerBase, Lyon
2.
go back to reference Mehanna H, Paleri V, West CML, Nutting C (2010) Head and neck cancer—Part 1: epidemiology, presentation, and prevention. Bmj 341:663–666 Mehanna H, Paleri V, West CML, Nutting C (2010) Head and neck cancer—Part 1: epidemiology, presentation, and prevention. Bmj 341:663–666
3.
go back to reference D’Souza G, Kreimer AR, Viscidi R et al (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956PubMedCrossRef D’Souza G, Kreimer AR, Viscidi R et al (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956PubMedCrossRef
4.
go back to reference Ryerson AB, Peters ES, Coughlin SS et al (2008) Burden of potentially human papillomavirus associated cancers of the oropharynx and oral cavity in the US. 1998-2003. Cancer 113:2901–2909PubMedCrossRef Ryerson AB, Peters ES, Coughlin SS et al (2008) Burden of potentially human papillomavirus associated cancers of the oropharynx and oral cavity in the US. 1998-2003. Cancer 113:2901–2909PubMedCrossRef
5.
go back to reference Sturgis EM, Cincinpini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papilloma virus-associated cancers. Cancer 110:1429–1435PubMedCrossRef Sturgis EM, Cincinpini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papilloma virus-associated cancers. Cancer 110:1429–1435PubMedCrossRef
7.
go back to reference De Martel C, Ferlay J, Franceschi S et al (2012) The global burden of cancers attributable to infections in the year 2008: a review and synthetic analysis. Lancet Oncol 13:607–615PubMedCrossRef De Martel C, Ferlay J, Franceschi S et al (2012) The global burden of cancers attributable to infections in the year 2008: a review and synthetic analysis. Lancet Oncol 13:607–615PubMedCrossRef
8.
go back to reference Kreimer AR, Bhatia RK, Messeguer AI et al (2010) Oral human papilloma virus in healthy individuals: a systematic review of the literature. Sex Transm Dis 37(6):386–391PubMed Kreimer AR, Bhatia RK, Messeguer AI et al (2010) Oral human papilloma virus in healthy individuals: a systematic review of the literature. Sex Transm Dis 37(6):386–391PubMed
9.
go back to reference Shousshtari AN, Rahimi NP, Schlesinger DJ, Read PW (2010) Survey on human papillomavirus/p16 screening use in oropharyngeal carcinoma patient in the United States. Cancer 116:514–519CrossRef Shousshtari AN, Rahimi NP, Schlesinger DJ, Read PW (2010) Survey on human papillomavirus/p16 screening use in oropharyngeal carcinoma patient in the United States. Cancer 116:514–519CrossRef
10.
go back to reference Thomas J, Primeaux T (2012) Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 16(2):91–99PubMedCrossRef Thomas J, Primeaux T (2012) Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 16(2):91–99PubMedCrossRef
11.
go back to reference Tringler B, Gup C, Singh M et al (2004) Evaluation of p16INK4a and pRB expression in cervical squamous and glandular neoplasia. Hum Pathol 35:659–695CrossRef Tringler B, Gup C, Singh M et al (2004) Evaluation of p16INK4a and pRB expression in cervical squamous and glandular neoplasia. Hum Pathol 35:659–695CrossRef
12.
go back to reference Samarawardana P, Dehn D, Singh MS et al (2010) P16INK4 is superior to high-risk human papilloma virus testing in cervical cytology for the prediction of underlying high-grade dysplasia. Cancer Cytopathol 118:146–156PubMedCrossRef Samarawardana P, Dehn D, Singh MS et al (2010) P16INK4 is superior to high-risk human papilloma virus testing in cervical cytology for the prediction of underlying high-grade dysplasia. Cancer Cytopathol 118:146–156PubMedCrossRef
13.
go back to reference Lewis JS, Thorstad WL, Chernock RD et al (2010) P16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 34:1088–1096PubMedCrossRef Lewis JS, Thorstad WL, Chernock RD et al (2010) P16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 34:1088–1096PubMedCrossRef
14.
go back to reference Hoffman M, Ihloff AS, Gorogh T et al (2010) p16 INK4a over-expression predicts translational active human papilloma virus infection in tonsillar cancer. Int J Cancer 127:1595–1602CrossRef Hoffman M, Ihloff AS, Gorogh T et al (2010) p16 INK4a over-expression predicts translational active human papilloma virus infection in tonsillar cancer. Int J Cancer 127:1595–1602CrossRef
15.
go back to reference Jemal A, Simard EP, Dorell C et al (2013) Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 105(3):175–201PubMedCentralPubMedCrossRef Jemal A, Simard EP, Dorell C et al (2013) Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 105(3):175–201PubMedCentralPubMedCrossRef
16.
go back to reference Marur S, D’Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789PubMedCrossRef Marur S, D’Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789PubMedCrossRef
17.
go back to reference Gillison ML, Broutian T, Pickard RKL et al (2012) Prevalence of Oral HPV Infection in the United States, 2009–2010. Jama 307(7):693–703PubMedCrossRef Gillison ML, Broutian T, Pickard RKL et al (2012) Prevalence of Oral HPV Infection in the United States, 2009–2010. Jama 307(7):693–703PubMedCrossRef
18.
go back to reference Rotnáglová E, Tachezy R, Saláková M et al (2011) HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. Int J Cancer 129(1):101–110PubMedCrossRef Rotnáglová E, Tachezy R, Saláková M et al (2011) HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. Int J Cancer 129(1):101–110PubMedCrossRef
19.
go back to reference O’Rorke MA, Ellison MV, Murray LJ et al (2012) Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis. Oral Oncol 48(12):1191–1201PubMedCrossRef O’Rorke MA, Ellison MV, Murray LJ et al (2012) Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysis. Oral Oncol 48(12):1191–1201PubMedCrossRef
20.
go back to reference Biron VL, Côté DW, Seikaly H (2011) Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association. J Otolaryngol Head Neck Surg 40(Suppl 1):S65–S69PubMed Biron VL, Côté DW, Seikaly H (2011) Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association. J Otolaryngol Head Neck Surg 40(Suppl 1):S65–S69PubMed
21.
go back to reference Chaturvedi AK, Engels EA, Gilbert ES et al (2007) Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 99(21):1634–1643PubMedCrossRef Chaturvedi AK, Engels EA, Gilbert ES et al (2007) Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 99(21):1634–1643PubMedCrossRef
22.
go back to reference Balamurugan A, Ahmed F, Saraiya M et al (2008) Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 113(Suppl 10):2919–2925PubMedCrossRef Balamurugan A, Ahmed F, Saraiya M et al (2008) Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Cancer 113(Suppl 10):2919–2925PubMedCrossRef
23.
go back to reference Lingen MW (2011) Brush-based cytology screening in the tonsils and cervix: there is a difference! Cancer Prev Res 4(9):1350–1352CrossRef Lingen MW (2011) Brush-based cytology screening in the tonsils and cervix: there is a difference! Cancer Prev Res 4(9):1350–1352CrossRef
24.
go back to reference Fakhry C, Rosenthal BT, Clark DP, Gillison ML (2011) Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal “Pap-test equivalent” in high-risk populations. Cancer Prev Res 4:1378–1384CrossRef Fakhry C, Rosenthal BT, Clark DP, Gillison ML (2011) Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal “Pap-test equivalent” in high-risk populations. Cancer Prev Res 4:1378–1384CrossRef
Metadata
Title
HPV-related cervical disease and oropharyngeal cancer
Authors
Virginia Lozza
Annalisa Pieralli
Serena Corioni
Manuela Longinotti
Claudia Bianchi
Daniela Moncini
Maria Grazia Fallani
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 2/2014
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3187-7

Other articles of this Issue 2/2014

Archives of Gynecology and Obstetrics 2/2014 Go to the issue